April 9, 2018 / 8:13 AM / in 18 days

BRIEF-Ekf Diagnostics Says US FDA Approval For Diaspect

April 9 (Reuters) - EKF Diagnostics Holdings PLC:

* US FDA 510(k) Clearance And Clia Waiver By Statute For Company’s Hand-Held Reagent-Free Hemoglobin Analyzer, Diaspect Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below